default author photo

Ewa Paszkiewicz-Kozik

Maria Sklodowska-Curie National Institute of Oncology

Krakow

Poland

SCHOLARLY PAPERS

1

DOWNLOADS

197

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

KEYNOTE-204: A Multicentre, Randomised, Open-Label, Phase 3 Study of Pembrolizumab versus Brentuximab Vedotin in Relapsed or Refractory Classical Hodgkin Lymphoma

Number of pages: 47 Posted: 12 Oct 2020
University of Toronto - Princess Margaret Cancer Centre, University of Tennessee, Knoxville, Humanitas University - Department of Biomedical Sciences, Maria Sklodowska-Curie National Institute of Oncology, The University of Sydney - Concord Hospital, Jewish General Hospital, Montreal, Hospital de Clinicas de Porto Alegre, Fundação Pio XII - Hospital de Câncer de Barretos, Casa de Saude Santa Marcelina, University of São Paulo (USP) - Hospital das Clínicas, Hospital Israelita Albert Einstein, Hebrew University of Jerusalem - Hadassah Medical Center, National Cancer Institute, Kiev, Peter MacCallum Cancer Centre, Szpital Kliniczny im. Przemienienia, Pretoria East Hospital, Ankara Üniversitesi Tip Fakültesi, National Hospital Organization Disaster Medical Center, Merck & Co., Inc., Merck & Co., Inc., Merck & Co., Inc., Universitaria di Bologna - Azienda Ospedaliero and Independent
Downloads 197 (393,598)

Abstract:

Loading...

Hodgkin lymphoma, pembrolizumab, PD-1